Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > Fund Triples Holding of Drug Repurposing Firm

<< Previous

Bullboard Posts

Next >>

Comment by C10H12N2on Jan 22, 2022 10:27pm

144 Views

Post# 34349004

RE:RE:RE:Fund Triples Holding of Drug Repurposing Firm

rotflmao as usual @ ur posts. lil stalker u. naw, i like this company (AGN) just fine now that a real cockroach is out of the pictiure. u kno, the fool u religiously fan over on other message boards? talk about hypocrisy. ur clueless as usual here. you rather keep ranting about me versus doing some due diligence to help yourself. whose the loser here? i post my truth. you post your lies. yet i'm the one who should be worried...rotflmao as usual @ ur posts.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec